Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Becton Dickinson; Genome ID Group; ResearchDx; ACMG, 5AM Solutions

NEW YORK (GenomeWeb News) – Becton Dickinson this week said its board has declared a quarterly dividend of $.545 per share payable on Dec. 31 to shareholders of record on Dec. 10. At the current rate, the annual dividend for Fiscal Year 2014 would be $2.18 per share, the company said.


The Genome ID Group has established The Center for Advanced Forensic DNA Analysis in Greenville, N.C. The center is a joint effort of Pitt County, Greenville, and the NC Biotech Center and currently has 10 employees with plans to increase that number to 130 and expand within its 11,000 square feet building "in line with business growth," it said. The new center is a full service forensic genomics lab, and offers forensic analysis of biological evidence from crime scenes.


Contract diagnostics organization ResearchDx has expanded into India, where it will partner with Indian firms developing companion diagnostics and in vitro diagnostic products. It also will help companies seeking CLIA accreditation, and ISO and CAP certification.


The American College of Medical Genetics and Genomics has extended its contract with 5AM Solutions as part of ACMG's recent five-year contract extension with the Eunice Kennedy Shriver National Institute of Child Health and Human Development for the Newborn Screening Translational Research Network Coordination Center. 5AM Solutions, an informatics and software solutions firm, will continue to "enhance the existing web-based Virtual Repository for Dried Blood Spots and the NBSTRN website," as part of the contract extension with ACMG, it said.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Filed under

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.